VOCAL: An observational study of ivacaftor for people with cystic fibrosis and selected non-G551D-CFTR gating mutations.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society(2023)

引用 1|浏览3
暂无评分
摘要
These results demonstrate the positive long-term effectiveness of ivacaftor on clinical outcomes and HCRU in pwCF with non-G551D-CFTR gating mutations in real-world settings.
更多
查看译文
关键词
CFTR gating mutation,Cystic fibrosis,Healthcare resource utilization,Ivacaftor,Lung function,Real-world experience
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要